Article(id=1329875961815872428, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329875908023922880, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2024.12.001, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1704384000000, receivedDateStr=2024-01-05, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794996737196, onlineDateStr=2026-11-18, pubDate=1733760000000, pubDateStr=2024-12-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794996737196, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794996737196, creator=13701087609, updateTime=1794996737196, updator=13701087609, issue=Issue{id=1329875908023922880, tenantId=1146029695717560320, journalId=1319690259887390882, year='2024', volume='55', issue='12', pageStart='1603', pageEnd='1728', issueExtLink='null', onlineDate='null', pubDate='1733760000000', pubDateStr='2024-12-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794996724372, creator='13701087609', updateTime=1794996724372, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext=null, issueFiles=null, downloadFileDto=null}, startPage=1603, endPage=1611, ext={EN=ArticleExt(id=1329875962000421805, articleId=1329875961815872428, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Research Progress of Atropine Ophthalmic Formulations for Myopia Prevention and Control, columnId=1327671134809600231, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Low-concentration atropine eyedrops, an ophthalmic formulation for delaying myopia of adolescents, has been widely recognized due to its clinical therapeutic effects. However, the commercialized atropine sulfate eyedrops, ophthalmic aqueous solution, have many problems, such as eye irritation caused by low pH value of the aqueous solution, poor stability of the preparations and poor patient compliance. In this review, the formulations and preparation processes of atropine sulfate ophthalmic preparations currently under development and on the market are summarized, the characteristics, advantages and disadvantages of various technical approaches for improving stability and compliance of atropine sulfate ophthalmic products are analyzed, hoping to provide some references for the optimization of atropine ophthalmic formulations.

, authors=Tao ZHANG1, 2, Cong HUANG2, Huiwen LIU2, Weiyue LU1, *, authorsList=Tao ZHANG, Cong HUANG, Huiwen LIU, Weiyue LU, authorCompany=null, correspAuthors=Weiyue LU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329875962201748399, articleId=1329875961815872428, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=近视防控用阿托品眼用制剂的研究进展, columnId=1327671135019315436, journalTitle=中国医药工业杂志, columnName=综述, runingTitle=null, highlight=null, articleAbstract=

低浓度阿托品滴眼剂作为延缓青少年近视的眼用制剂,临床疗效已得到广泛认可,但已上市的硫酸阿托品水溶液型滴眼剂存在因pH值低而导致的眼刺激性、制剂稳定性差和患者依从性差等问题。该文对目前在研和在售的硫酸阿托品眼用制剂的处方和制备工艺进行了文献调研和总结,分析了各种改善硫酸阿托品眼用制剂稳定性和依从性的技术方案特点和优劣势,以期为阿托品眼用制剂的优化提供一定的参考。

, authors=张涛1, 2, 黄聪2, 刘会文2, 陆伟跃1, *, authorsList=张涛, 黄聪, 刘会文, 陆伟跃, authorCompany=null, correspAuthors=陆伟跃, authorNote=

张涛(1983—),男,博士研究生,专业方向:生物与医药。

, correspAuthorsNote=
陆伟跃(1960—),男,教授,从事药物靶向策略及递药系统研究。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=+M24Bu3HlfZIsZR7mCOahg==, magXml=V1YI6+a+541qE3uLSqoIww==, pdfUrl=null, pdf=ftbiz/3vEI8K9ELtRugZJA==, pdfFileSize=3258731, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=9nAvJ+DXxP5AaXkaFEuBrw==, mapNumber=null, fund=null)}, authors=[Author(id=1329875962520515511, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329875962608595898, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, authorId=1329875962520515511, language=EN, stringName=Tao ZHANG, firstName=Tao, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.School of Pharmacy, Fudan University, Shanghai 201203
2.Cloudbreak Bio-Pharmaceutical Science and Technology (Gaungzhou)Co., Ltd., Guangzhou 510663, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329875962671510459, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, authorId=1329875962520515511, language=CN, stringName=张涛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.复旦大学药学院,上海 201203
2.拨康视云生物医药科技(广州)有限公司,广东 广州 510663, bio={"content":"

张涛(1983—),男,博士研究生,专业方向:生物与医药。

"}, bioImg=null, bioContent=

张涛(1983—),男,博士研究生,专业方向:生物与医药。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329875962369520560, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, xref=1., ext=[AuthorCompanyExt(id=1329875962377909169, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, companyId=1329875962369520560, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Fudan University, Shanghai 201203), AuthorCompanyExt(id=1329875962390492082, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, companyId=1329875962369520560, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学药学院,上海 201203)]), AuthorCompany(id=1329875962449212339, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, xref=2., ext=[AuthorCompanyExt(id=1329875962457600948, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, companyId=1329875962449212339, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Cloudbreak Bio-Pharmaceutical Science and Technology (Gaungzhou)Co., Ltd., Guangzhou 510663), AuthorCompanyExt(id=1329875962465989557, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, companyId=1329875962449212339, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.拨康视云生物医药科技(广州)有限公司,广东 广州 510663)])]), Author(id=1329875962742813629, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329875962814116799, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, authorId=1329875962742813629, language=EN, stringName=Cong HUANG, firstName=Cong, middleName=null, lastName=HUANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Cloudbreak Bio-Pharmaceutical Science and Technology (Gaungzhou)Co., Ltd., Guangzhou 510663, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329875962885419968, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, authorId=1329875962742813629, language=CN, stringName=黄聪, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.拨康视云生物医药科技(广州)有限公司,广东 广州 510663, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329875962449212339, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, xref=2., ext=[AuthorCompanyExt(id=1329875962457600948, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, companyId=1329875962449212339, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Cloudbreak Bio-Pharmaceutical Science and Technology (Gaungzhou)Co., Ltd., Guangzhou 510663), AuthorCompanyExt(id=1329875962465989557, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, companyId=1329875962449212339, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.拨康视云生物医药科技(广州)有限公司,广东 广州 510663)])]), Author(id=1329875962948334530, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329875963028026308, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, authorId=1329875962948334530, language=EN, stringName=Huiwen LIU, firstName=Huiwen, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Cloudbreak Bio-Pharmaceutical Science and Technology (Gaungzhou)Co., Ltd., Guangzhou 510663, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329875963103523782, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, authorId=1329875962948334530, language=CN, stringName=刘会文, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.拨康视云生物医药科技(广州)有限公司,广东 广州 510663, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329875962449212339, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, xref=2., ext=[AuthorCompanyExt(id=1329875962457600948, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, companyId=1329875962449212339, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Cloudbreak Bio-Pharmaceutical Science and Technology (Gaungzhou)Co., Ltd., Guangzhou 510663), AuthorCompanyExt(id=1329875962465989557, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, companyId=1329875962449212339, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.拨康视云生物医药科技(广州)有限公司,广东 广州 510663)])]), Author(id=1329875963183215560, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=wylu@shmu.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329875963254518730, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, authorId=1329875963183215560, language=EN, stringName=Weiyue LU, firstName=Weiyue, middleName=null, lastName=LU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.School of Pharmacy, Fudan University, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329875963325821899, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, authorId=1329875963183215560, language=CN, stringName=陆伟跃, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.复旦大学药学院,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329875962369520560, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, xref=1., ext=[AuthorCompanyExt(id=1329875962377909169, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, companyId=1329875962369520560, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Fudan University, Shanghai 201203), AuthorCompanyExt(id=1329875962390492082, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, companyId=1329875962369520560, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学药学院,上海 201203)])])], keywords=[Keyword(id=1329875963434873804, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, language=EN, orderNo=1, keyword=atropine), Keyword(id=1329875963501982669, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, language=EN, orderNo=2, keyword=myopia), Keyword(id=1329875963564897230, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, language=EN, orderNo=3, keyword=ophthalmic formulation), Keyword(id=1329875963623617487, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, language=EN, orderNo=4, keyword=eyedrops), Keyword(id=1329875963711697872, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, language=EN, orderNo=5, keyword=research progress), Keyword(id=1329875963778806737, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, language=CN, orderNo=1, keyword=阿托品), Keyword(id=1329875963841721298, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, language=CN, orderNo=2, keyword=近视), Keyword(id=1329875963896247251, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, language=CN, orderNo=3, keyword=眼用制剂), Keyword(id=1329875963963356116, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, language=CN, orderNo=4, keyword=滴眼剂), Keyword(id=1329875964030464981, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, language=CN, orderNo=5, keyword=研究进展)], refs=[Reference(id=1329875964114351062, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=HOLDEN B A, FRICKE T R, WILSON D A, et al.Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050 [J].Ophthalmology, 2016, 123(5): 1036-1042., articleTitle=null, refAbstract=null), Reference(id=1329875964240180183, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=MORGAN I G, FRENCH A N, ASHBY R S, et al.The epidemics of myopia: aetiology and prevention [J].Prog Retin Eye Res, 2018, 62: 134-149., articleTitle=null, refAbstract=null), Reference(id=1329875964307289048, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=樊星砚,熊殷,王亦凡,等.阿托品治疗近视研究进展[J].中国医药工业杂志,2021,52(9):1161-1168., articleTitle=null, refAbstract=null), Reference(id=1329875964374397913, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=WILDSOET C F, CHIA A, CHO P, et al.IMI - Interventions Myopia Institute: interventions for controlling myopia onset and progression report [J].Invest Ophthalmol Vis Sci, 2019, 60(3): M106-M131., articleTitle=null, refAbstract=null), Reference(id=1329875964416340954, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=GIFFORD K L, RICHDALE K, KANG P, et al.IMI: clinical management guidelines report [J].Invest Ophthalmol Vis Sci, 2019, 60(3): M184-M203., articleTitle=null, refAbstract=null), Reference(id=1329875964466672603, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=WOLFFSOHN J S, KOLLBAUM P S, BERNTSEN D A, et al.IMI: clinical myopia control trials and instrumentation report [J].Invest Ophthalmol Vis Sci, 2019, 60(3): M132-M160., articleTitle=null, refAbstract=null), Reference(id=1329875964533781468, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=CAO K, WAN Y, YUSUFU M, et al.Significance of outdoor time for myopia prevention: a systematic review and meta-analysis based on randomized controlled trials [J].Ophthalmic Res, 2020, 63(2): 97-105., articleTitle=null, refAbstract=null), Reference(id=1329875964600890333, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=WU P C, TSAI C L, WU H L, et al.Outdoor activity during class recess reduces myopia onset and progression in school children [J].Ophthalmology, 2013, 120(5): 1080-1085., articleTitle=null, refAbstract=null), Reference(id=1329875964688970718, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=SANKARIDURG P, DONOVAN L, VARNAS S, et al.Spectacle lenses designed to reduce progression of myopia:12-month results [J].Optom Vis Sci, 2010, 87(9): 631-641., articleTitle=null, refAbstract=null), Reference(id=1329875964865131487, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=蒲艳妮,车红芳.角膜塑形镜与普通框架眼镜在青少年近视中的应用效果比较[J].临床医学研究与实践,2023,8(18):94-97., articleTitle=null, refAbstract=null), Reference(id=1329875964986766304, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=LI S Y, LI S M, ZHOU Y H, et al.Effect of undercorrection on myopia progression in 12-year-old children [J].Graefes Arch Clin Exp Ophthalmol, 2015, 253(8): 1363-1368., articleTitle=null, refAbstract=null), Reference(id=1329875965074846689, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=SUN Y Y, LI S M, LI S Y, et al.Effect of uncorrection versus full correction on myopia progression in 12-year-old children[J].Graefes Arch Clin Exp Ophthalmol, 2017, 255(1): 189-195., articleTitle=null, refAbstract=null), Reference(id=1329875965125178338, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=CHARM J, CHO P.High myopia-partial reduction orthoker-atology (HM-PRO): study design [J].Cont Lens Anterior Eye, 2013, 36(4): 164-170., articleTitle=null, refAbstract=null), Reference(id=1329875965188092899, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=SWARBRICK H A, ALHARBI A, WATT K, et al.Myopia control during orthokeratology lens wear in children using a novel study design [J].Ophthalmology, 2015, 122(3): 620-630., articleTitle=null, refAbstract=null), Reference(id=1329875965263590372, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=黄建峰,张晓培,李童燕,等.角膜塑形镜离焦技术在近视防控中的研究进展[J].国际眼科杂志,2023,23(4):578-581., articleTitle=null, refAbstract=null), Reference(id=1329875965326504933, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=李鑫,窦晓燕.角膜塑形镜在近视防控的研究进展[J].临床眼科杂志,2018,26(2):187-191., articleTitle=null, refAbstract=null), Reference(id=1329875965393613798, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU C F, LEE J S, SUN C C, et al.Correlation between pigmented arc and epithelial thickness (COPE) study in orthokeratology-treated patients using OCT measurements [J].Eye (Lond), 2020, 34(2): 352-359., articleTitle=null, refAbstract=null), Reference(id=1329875965469111271, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU Y M, XIE P.The safety of orthokeratology--a systematic review [J].Eye Contact Lens, 2016, 42(1): 35-42., articleTitle=null, refAbstract=null), Reference(id=1329875965515248616, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=GISPETS J, YÉBANA P, LUPÓN N, et al.Efficacy, predictability and safety of long-term orthokeratology: an 18-year follow-up study [J].Cont Lens Anterior Eye, 2022, 45(1): 101530., articleTitle=null, refAbstract=null), Reference(id=1329875965573968873, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=REMÓN L, PÉREZ-MERINO P, MACEDO-DE-ARAÚJO R J,et al.Bifocal and multifocal contact lenses for presbyopia and myopia control [J].J Ophthalmol, 2020, 2020: 8067657., articleTitle=null, refAbstract=null), Reference(id=1329875965657854954, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=PAUNÉ J, MORALES H, ARMENGOL J, et al.Myopia control with a novel peripheral gradient soft lens and orthokeratology: a 2-year clinical trial [J].Biomed Res Int, 2015, 2015: 507572., articleTitle=null, refAbstract=null), Reference(id=1329875965758518251, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=CHENG X, XU J, CHEHAB K, et al.Soft contact lenses with positive spherical aberration for myopia control [J].Optom Vis Sci, 2016, 93(4): 353-366., articleTitle=null, refAbstract=null), Reference(id=1329875965821432812, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=代诚.多焦点软性角膜接触镜应用研究进展[J].山东大学耳鼻喉眼学报,2022,36(5):100-105., articleTitle=null, refAbstract=null), Reference(id=1329875965884347373, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=HUANG X, WANG F, LIN Z, et al.Visual quality of juvenile myopes wearing multifocal soft contact lenses [J].Eye Vis(Lond), 2020, 7: 41., articleTitle=null, refAbstract=null), Reference(id=1329875965951456238, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=TRIER K, MUNK RIBEL-MADSEN S, CUI D, et al.Systemic 7-methylxanthine in retarding axial eye growth and myopia progression: a 36-month pilot study [J].J Ocul Biol Dis Infor, 2008, 1(2-4): 85-93., articleTitle=null, refAbstract=null), Reference(id=1329875966026953711, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=LI X, WU M, ZHANG L, et al.Riboflavin and ultraviolet A irradiation for the prevention of progressive myopia in a guinea pig model [J].Exp Eye Res, 2017, 165: 1-6., articleTitle=null, refAbstract=null), Reference(id=1329875966106645488, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Lion Corp.Therapeutic agent for pseudomyopia: JP, 2011011984A [P].2011-01-20., articleTitle=null, refAbstract=null), Reference(id=1329875966156977137, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=张坚寅,俞全,徐海萍,等.托吡卡胺滴眼液防治青少年假性近视的临床观察[J].临床医学,2008,28(6):31-32., articleTitle=null, refAbstract=null), Reference(id=1329875966471549938, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=新加坡保健服务集团,参天制药株式会社.包含噻托铵作为活性成分的用于预防近视、治疗近视、及/或预防近视进展的药剂:中国,110505876A [P].2019-11-26., articleTitle=null, refAbstract=null), Reference(id=1329875966538658803, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=CHIA A, LU Q S, TAN D.Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eyedrops [J].Ophthalmology, 2016, 123(2): 391-399., articleTitle=null, refAbstract=null), Reference(id=1329875966597379060, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=YAM J C, JIANG Y, TANG S M, et al.Low-concentration atropine for myopia progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control [J].Ophthalmology, 2019, 126(1): 113-124., articleTitle=null, refAbstract=null), Reference(id=1329875966656099317, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHAO C, CAI C, DING Q, et al.Efficacy and safety of atropine to control myopia progression: a systematic review and meta-analysis [J].BMC Ophthalmol, 2020, 20(1): 478., articleTitle=null, refAbstract=null), Reference(id=1329875966714819574, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=NÉMETH J, TAPASZTÓ B, ACLIMANDOS W A, et al.Update and guidance on management of myopia.European Society of Ophthalmology in cooperation with International Myopia Institute [J].Eur J Ophthalmol, 2021, 31(3): 853-883., articleTitle=null, refAbstract=null), Reference(id=1329875966781928439, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=WALLINE J J, LINDSLEY K B, VEDULA S S, et al.Interventions to slow progression of myopia in children [J].Cochrane Database Syst Rev, 2020, 1(1): CD004916., articleTitle=null, refAbstract=null), Reference(id=1329875966849037304, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=BERTON B, CHENNELL P, YESSAAD M, et al.Stability of ophthalmic atropine solutions for child myopia control [J].Pharmaceutics, 2020, 12(8): 781., articleTitle=null, refAbstract=null), Reference(id=1329875966911951865, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=KIRCHHOFF C, BITAR Y, EBEL S, et al.Analysis of atropine, its degradation products and related substances of natural origin by means of reversed-phase high-performance liquid chromatography [J].J Chromatogr A, 2004, 1046(1/2): 115-120., articleTitle=null, refAbstract=null), Reference(id=1329875966970672122, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=SAITO J, IMAIZUMI H, YAMATANI A.Physical, chemical, and microbiological stability study of diluted atropine eye drops [J].J Pharm Health Care Sci, 2019, 5: 25., articleTitle=null, refAbstract=null), Reference(id=1329875967033586683, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=PINELES S L, KRAKER R T, VANDERVEEN D K, et al.Atropine for the prevention of myopia progression in children: a report by the american academy of ophthalmology [J].Ophthalmology, 2017, 124(12): 1857-1866., articleTitle=null, refAbstract=null), Reference(id=1329875967100695548, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=内瓦卡有限公司.阿托品药物组合物:中国,110621298A[P].2019-12-27., articleTitle=null, refAbstract=null), Reference(id=1329875967163610109, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=沈阳兴齐眼药股份有限公司.一种防治青少年近视的眼用制剂及其制备方法:中国,110833526A [P].2020-02-25., articleTitle=null, refAbstract=null), Reference(id=1329875967222330366, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=河北科技大学.一种治疗近视的滴眼剂及其制备方法:中国,110917133A [P].2020-03-27., articleTitle=null, refAbstract=null), Reference(id=1329875967285244927, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=欧普康视科技股份有限公司.一种延缓治疗青少年近视的滴眼液及其制备方法:中国,112402372A [P].2021-02-26., articleTitle=null, refAbstract=null), Reference(id=1329875967348159488, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=江苏恒瑞医药股份有限公司.一种药物组合物:中国,114668762A [P].2022-06-28., articleTitle=null, refAbstract=null), Reference(id=1329875967402684416, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=杭州赫尔斯科技有限公司.复方药物组合物滴眼液、其制备方法和应用:中国,110974970A [P].2020-04-10., articleTitle=null, refAbstract=null), Reference(id=1329875967469793281, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=杭州赫尔斯科技有限公司.增强低浓度阿托品类药物安全性和临床疗效的组合物:中国,109675038A [P].2019-04-26., articleTitle=null, refAbstract=null), Reference(id=1329875967557873666, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=南京恒道医药科技有限公司.一种硫酸阿托品滴眼液及其制备方法与应用:中国,113262201A [P].2021-08-17., articleTitle=null, refAbstract=null), Reference(id=1329875967641759747, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=新加坡保健服务集团,南洋理工大学,参天制药株式会社.含有阿托品的水性组合物:中国,109310687A [P].2019-02-05., articleTitle=null, refAbstract=null), Reference(id=1329875967738228740, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=OSTROW G I, WIDDER K J, BAKER D S.D2O stabilized pharmaceutical formulations: WO, 2016/196367 A1 [P].2016-12-08., articleTitle=null, refAbstract=null), Reference(id=1329875967801143301, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=艾诺维亚股份有限公司.用于以微剂量的液滴流向眼睛递送阿托品的方法和装置:中国,111655231A [P].2020-09-11., articleTitle=null, refAbstract=null), Reference(id=1329875967868252166, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[51], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=苏州欧康维视生物科技有限公司.一种用于预防或治疗眼科疾病的滴眼剂组合物及其制备方法:中国,113440486A [P].2021-09-28., articleTitle=null, refAbstract=null), Reference(id=1329875967926972423, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[52], rfOrder=50, authorNames=null, journalName=null, refType=null, unstructuredReference=沈阳兴齐眼科医院有限公司.药物组合物、其制备方法和用途:中国,114533652A [P].2022-05-27., articleTitle=null, refAbstract=null), Reference(id=1329875967994081288, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[53], rfOrder=51, authorNames=null, journalName=null, refType=null, unstructuredReference=沈阳兴齐眼科医院有限公司.一种提高低浓度阿托品眼用制剂稳定性的方法:中国,110934816B [P].2022-04-08., articleTitle=null, refAbstract=null), Reference(id=1329875968056995849, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[54], rfOrder=52, authorNames=null, journalName=null, refType=null, unstructuredReference=BAUDOUIN C, LABBÉ A, LIANG H, et al.Preservatives in eyedrops: the good, the bad and the ugly [J].Prog Retin Eye Res, 2010, 29(4): 312-334., articleTitle=null, refAbstract=null), Reference(id=1329875968111521802, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[55], rfOrder=53, authorNames=null, journalName=null, refType=null, unstructuredReference=山西利普达医药科技有限公司.一种眼用药物乳剂组合物及其制备方法和应用:中国,114588110B [P].2023-08-04., articleTitle=null, refAbstract=null), Reference(id=1329875968174436363, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[56], rfOrder=54, authorNames=null, journalName=null, refType=null, unstructuredReference=沈阳兴齐眼药股份有限公司.硫酸阿托品眼用凝胶:中国,1206988C [P].2005-06-22., articleTitle=null, refAbstract=null), Reference(id=1329875968233156620, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[57], rfOrder=55, authorNames=null, journalName=null, refType=null, unstructuredReference=肖正连.一种硫酸阿托品眼用即型凝胶:中国,101327216A [P].2008-12-24., articleTitle=null, refAbstract=null), Reference(id=1329875968308654093, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[58], rfOrder=56, authorNames=null, journalName=null, refType=null, unstructuredReference=NI J, YANG R.Topical ophthalmological atropine free base compositions: US, 11191751 [P].2021-12-07., articleTitle=null, refAbstract=null), Reference(id=1329875968371568654, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[59], rfOrder=57, authorNames=null, journalName=null, refType=null, unstructuredReference=MEINERT H, ROY T.Semifluorinated alkanes--a new class of compounds with outstanding properties for use in ophthalmology [J].Eur J Ophthalmol, 2000, 10(3): 189-197., articleTitle=null, refAbstract=null), Reference(id=1329875968430288911, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[60], rfOrder=58, authorNames=null, journalName=null, refType=null, unstructuredReference=AGARWAL P, SCHERER D, GÜNTHER B, et al.Semifluorinated alkane based systems for enhanced corneal penetration of poorly soluble drugs [J].Int J Pharm, 2018, 538(1/2): 119-129., articleTitle=null, refAbstract=null), Reference(id=1329875968501592080, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[61], rfOrder=59, authorNames=null, journalName=null, refType=null, unstructuredReference=沈阳药科大学.一种硫酸阿托品眼用膜剂及其制备方法:中国,111358771B [P]. 2023-01-10., articleTitle=null, refAbstract=null), Reference(id=1329875968556118033, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[62], rfOrder=60, authorNames=null, journalName=null, refType=null, unstructuredReference=JI M, LIU H, MA S, et al.Stable atropine loaded film as a potential ocular delivery system for treatment of myopia [J].Pharm Res, 2021, 38(11): 1931-1946., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329875962369520560, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, xref=1., ext=[AuthorCompanyExt(id=1329875962377909169, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, companyId=1329875962369520560, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Fudan University, Shanghai 201203), AuthorCompanyExt(id=1329875962390492082, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, companyId=1329875962369520560, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学药学院,上海 201203)]), AuthorCompany(id=1329875962449212339, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, xref=2., ext=[AuthorCompanyExt(id=1329875962457600948, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, companyId=1329875962449212339, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Cloudbreak Bio-Pharmaceutical Science and Technology (Gaungzhou)Co., Ltd., Guangzhou 510663), AuthorCompanyExt(id=1329875962465989557, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, companyId=1329875962449212339, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.拨康视云生物医药科技(广州)有限公司,广东 广州 510663)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.12.001, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2024.12.001, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2024.12.001, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2024.12.001, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1733760000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
近视防控用阿托品眼用制剂的研究进展
张涛 1, 2 , 黄聪 2 , 刘会文 2 , 陆伟跃 1, *
中国医药工业杂志 | 综述 2024,55(12): 1603-1611
收起
收藏切换
中国医药工业杂志 |综述 2024 , 55 (12) : 1603 -1611
近视防控用阿托品眼用制剂的研究进展
全屏
[Author(id=1329875962520515511, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329875962608595898, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, authorId=1329875962520515511, language=EN, stringName=Tao ZHANG, firstName=Tao, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.School of Pharmacy, Fudan University, Shanghai 201203
2.Cloudbreak Bio-Pharmaceutical Science and Technology (Gaungzhou)Co., Ltd., Guangzhou 510663, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329875962671510459, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, authorId=1329875962520515511, language=CN, stringName=张涛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.复旦大学药学院,上海 201203
2.拨康视云生物医药科技(广州)有限公司,广东 广州 510663, bio={"content":"

张涛(1983—),男,博士研究生,专业方向:生物与医药。

"}, bioImg=null, bioContent=

张涛(1983—),男,博士研究生,专业方向:生物与医药。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329875962369520560, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, xref=1., ext=[AuthorCompanyExt(id=1329875962377909169, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, companyId=1329875962369520560, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Fudan University, Shanghai 201203), AuthorCompanyExt(id=1329875962390492082, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, companyId=1329875962369520560, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学药学院,上海 201203)]), AuthorCompany(id=1329875962449212339, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, xref=2., ext=[AuthorCompanyExt(id=1329875962457600948, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, companyId=1329875962449212339, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Cloudbreak Bio-Pharmaceutical Science and Technology (Gaungzhou)Co., Ltd., Guangzhou 510663), AuthorCompanyExt(id=1329875962465989557, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, companyId=1329875962449212339, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.拨康视云生物医药科技(广州)有限公司,广东 广州 510663)])]), Author(id=1329875962742813629, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329875962814116799, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, authorId=1329875962742813629, language=EN, stringName=Cong HUANG, firstName=Cong, middleName=null, lastName=HUANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Cloudbreak Bio-Pharmaceutical Science and Technology (Gaungzhou)Co., Ltd., Guangzhou 510663, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329875962885419968, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, authorId=1329875962742813629, language=CN, stringName=黄聪, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.拨康视云生物医药科技(广州)有限公司,广东 广州 510663, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329875962449212339, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, xref=2., ext=[AuthorCompanyExt(id=1329875962457600948, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, companyId=1329875962449212339, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Cloudbreak Bio-Pharmaceutical Science and Technology (Gaungzhou)Co., Ltd., Guangzhou 510663), AuthorCompanyExt(id=1329875962465989557, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, companyId=1329875962449212339, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.拨康视云生物医药科技(广州)有限公司,广东 广州 510663)])]), Author(id=1329875962948334530, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329875963028026308, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, authorId=1329875962948334530, language=EN, stringName=Huiwen LIU, firstName=Huiwen, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Cloudbreak Bio-Pharmaceutical Science and Technology (Gaungzhou)Co., Ltd., Guangzhou 510663, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329875963103523782, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, authorId=1329875962948334530, language=CN, stringName=刘会文, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.拨康视云生物医药科技(广州)有限公司,广东 广州 510663, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329875962449212339, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, xref=2., ext=[AuthorCompanyExt(id=1329875962457600948, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, companyId=1329875962449212339, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Cloudbreak Bio-Pharmaceutical Science and Technology (Gaungzhou)Co., Ltd., Guangzhou 510663), AuthorCompanyExt(id=1329875962465989557, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, companyId=1329875962449212339, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.拨康视云生物医药科技(广州)有限公司,广东 广州 510663)])]), Author(id=1329875963183215560, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=wylu@shmu.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329875963254518730, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, authorId=1329875963183215560, language=EN, stringName=Weiyue LU, firstName=Weiyue, middleName=null, lastName=LU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.School of Pharmacy, Fudan University, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329875963325821899, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, authorId=1329875963183215560, language=CN, stringName=陆伟跃, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.复旦大学药学院,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329875962369520560, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, xref=1., ext=[AuthorCompanyExt(id=1329875962377909169, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, companyId=1329875962369520560, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Fudan University, Shanghai 201203), AuthorCompanyExt(id=1329875962390492082, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329875961815872428, companyId=1329875962369520560, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学药学院,上海 201203)])])]
张涛1, 2, 黄聪2, 刘会文2, 陆伟跃1, *
作者信息
  • 1.复旦大学药学院,上海 201203
  • 2.拨康视云生物医药科技(广州)有限公司,广东 广州 510663
通讯作者:
陆伟跃(1960—),男,教授,从事药物靶向策略及递药系统研究。E-mail:
作者简介:

张涛(1983—),男,博士研究生,专业方向:生物与医药。

Research Progress of Atropine Ophthalmic Formulations for Myopia Prevention and Control
Tao ZHANG1, 2, Cong HUANG2, Huiwen LIU2, Weiyue LU1, *
Affiliations
  • 1.School of Pharmacy, Fudan University, Shanghai 201203
  • 2.Cloudbreak Bio-Pharmaceutical Science and Technology (Gaungzhou)Co., Ltd., Guangzhou 510663
出版时间: 2024-12-10 doi: 10.16522/j.cnki.cjph.2024.12.001
文章导航
收藏切换

低浓度阿托品滴眼剂作为延缓青少年近视的眼用制剂,临床疗效已得到广泛认可,但已上市的硫酸阿托品水溶液型滴眼剂存在因pH值低而导致的眼刺激性、制剂稳定性差和患者依从性差等问题。该文对目前在研和在售的硫酸阿托品眼用制剂的处方和制备工艺进行了文献调研和总结,分析了各种改善硫酸阿托品眼用制剂稳定性和依从性的技术方案特点和优劣势,以期为阿托品眼用制剂的优化提供一定的参考。

阿托品  /  近视  /  眼用制剂  /  滴眼剂  /  研究进展

Low-concentration atropine eyedrops, an ophthalmic formulation for delaying myopia of adolescents, has been widely recognized due to its clinical therapeutic effects. However, the commercialized atropine sulfate eyedrops, ophthalmic aqueous solution, have many problems, such as eye irritation caused by low pH value of the aqueous solution, poor stability of the preparations and poor patient compliance. In this review, the formulations and preparation processes of atropine sulfate ophthalmic preparations currently under development and on the market are summarized, the characteristics, advantages and disadvantages of various technical approaches for improving stability and compliance of atropine sulfate ophthalmic products are analyzed, hoping to provide some references for the optimization of atropine ophthalmic formulations.

atropine  /  myopia  /  ophthalmic formulation  /  eyedrops  /  research progress
张涛, 黄聪, 刘会文, 陆伟跃. 近视防控用阿托品眼用制剂的研究进展. 中国医药工业杂志, 2024 , 55 (12) : 1603 -1611 . DOI: 10.16522/j.cnki.cjph.2024.12.001
Tao ZHANG, Cong HUANG, Huiwen LIU, Weiyue LU. Research Progress of Atropine Ophthalmic Formulations for Myopia Prevention and Control[J]. Chinese Journal of Pharmaceuticals, 2024 , 55 (12) : 1603 -1611 . DOI: 10.16522/j.cnki.cjph.2024.12.001

参考文献 引证文献
排序方式:
[1]
HOLDEN B A, FRICKE T R, WILSON D A, et al.Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050 [J].Ophthalmology, 2016, 123(5): 1036-1042.
[2]
MORGAN I G, FRENCH A N, ASHBY R S, et al.The epidemics of myopia: aetiology and prevention [J].Prog Retin Eye Res, 2018, 62: 134-149.
[3]
樊星砚,熊殷,王亦凡,等.阿托品治疗近视研究进展[J].中国医药工业杂志,2021,52(9):1161-1168.
[4]
WILDSOET C F, CHIA A, CHO P, et al.IMI - Interventions Myopia Institute: interventions for controlling myopia onset and progression report [J].Invest Ophthalmol Vis Sci, 2019, 60(3): M106-M131.
[5]
GIFFORD K L, RICHDALE K, KANG P, et al.IMI: clinical management guidelines report [J].Invest Ophthalmol Vis Sci, 2019, 60(3): M184-M203.
[6]
WOLFFSOHN J S, KOLLBAUM P S, BERNTSEN D A, et al.IMI: clinical myopia control trials and instrumentation report [J].Invest Ophthalmol Vis Sci, 2019, 60(3): M132-M160.
[7]
CAO K, WAN Y, YUSUFU M, et al.Significance of outdoor time for myopia prevention: a systematic review and meta-analysis based on randomized controlled trials [J].Ophthalmic Res, 2020, 63(2): 97-105.
[8]
WU P C, TSAI C L, WU H L, et al.Outdoor activity during class recess reduces myopia onset and progression in school children [J].Ophthalmology, 2013, 120(5): 1080-1085.
[9]
SANKARIDURG P, DONOVAN L, VARNAS S, et al.Spectacle lenses designed to reduce progression of myopia:12-month results [J].Optom Vis Sci, 2010, 87(9): 631-641.
[10]
蒲艳妮,车红芳.角膜塑形镜与普通框架眼镜在青少年近视中的应用效果比较[J].临床医学研究与实践,2023,8(18):94-97.
[11]
LI S Y, LI S M, ZHOU Y H, et al.Effect of undercorrection on myopia progression in 12-year-old children [J].Graefes Arch Clin Exp Ophthalmol, 2015, 253(8): 1363-1368.
[12]
SUN Y Y, LI S M, LI S Y, et al.Effect of uncorrection versus full correction on myopia progression in 12-year-old children[J].Graefes Arch Clin Exp Ophthalmol, 2017, 255(1): 189-195.
[13]
CHARM J, CHO P.High myopia-partial reduction orthoker-atology (HM-PRO): study design [J].Cont Lens Anterior Eye, 2013, 36(4): 164-170.
[14]
SWARBRICK H A, ALHARBI A, WATT K, et al.Myopia control during orthokeratology lens wear in children using a novel study design [J].Ophthalmology, 2015, 122(3): 620-630.
[15]
黄建峰,张晓培,李童燕,等.角膜塑形镜离焦技术在近视防控中的研究进展[J].国际眼科杂志,2023,23(4):578-581.
[16]
李鑫,窦晓燕.角膜塑形镜在近视防控的研究进展[J].临床眼科杂志,2018,26(2):187-191.
[17]
LIU C F, LEE J S, SUN C C, et al.Correlation between pigmented arc and epithelial thickness (COPE) study in orthokeratology-treated patients using OCT measurements [J].Eye (Lond), 2020, 34(2): 352-359.
[18]
LIU Y M, XIE P.The safety of orthokeratology--a systematic review [J].Eye Contact Lens, 2016, 42(1): 35-42.
[19]
GISPETS J, YÉBANA P, LUPÓN N, et al.Efficacy, predictability and safety of long-term orthokeratology: an 18-year follow-up study [J].Cont Lens Anterior Eye, 2022, 45(1): 101530.
[20]
REMÓN L, PÉREZ-MERINO P, MACEDO-DE-ARAÚJO R J,et al.Bifocal and multifocal contact lenses for presbyopia and myopia control [J].J Ophthalmol, 2020, 2020: 8067657.
[21]
PAUNÉ J, MORALES H, ARMENGOL J, et al.Myopia control with a novel peripheral gradient soft lens and orthokeratology: a 2-year clinical trial [J].Biomed Res Int, 2015, 2015: 507572.
[22]
CHENG X, XU J, CHEHAB K, et al.Soft contact lenses with positive spherical aberration for myopia control [J].Optom Vis Sci, 2016, 93(4): 353-366.
[23]
代诚.多焦点软性角膜接触镜应用研究进展[J].山东大学耳鼻喉眼学报,2022,36(5):100-105.
[24]
HUANG X, WANG F, LIN Z, et al.Visual quality of juvenile myopes wearing multifocal soft contact lenses [J].Eye Vis(Lond), 2020, 7: 41.
[25]
TRIER K, MUNK RIBEL-MADSEN S, CUI D, et al.Systemic 7-methylxanthine in retarding axial eye growth and myopia progression: a 36-month pilot study [J].J Ocul Biol Dis Infor, 2008, 1(2-4): 85-93.
[26]
LI X, WU M, ZHANG L, et al.Riboflavin and ultraviolet A irradiation for the prevention of progressive myopia in a guinea pig model [J].Exp Eye Res, 2017, 165: 1-6.
[27]
Lion Corp.Therapeutic agent for pseudomyopia: JP, 2011011984A [P].2011-01-20.
[28]
张坚寅,俞全,徐海萍,等.托吡卡胺滴眼液防治青少年假性近视的临床观察[J].临床医学,2008,28(6):31-32.
[29]
新加坡保健服务集团,参天制药株式会社.包含噻托铵作为活性成分的用于预防近视、治疗近视、及/或预防近视进展的药剂:中国,110505876A [P].2019-11-26.
[30]
CHIA A, LU Q S, TAN D.Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eyedrops [J].Ophthalmology, 2016, 123(2): 391-399.
[31]
YAM J C, JIANG Y, TANG S M, et al.Low-concentration atropine for myopia progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control [J].Ophthalmology, 2019, 126(1): 113-124.
[32]
ZHAO C, CAI C, DING Q, et al.Efficacy and safety of atropine to control myopia progression: a systematic review and meta-analysis [J].BMC Ophthalmol, 2020, 20(1): 478.
[33]
NÉMETH J, TAPASZTÓ B, ACLIMANDOS W A, et al.Update and guidance on management of myopia.European Society of Ophthalmology in cooperation with International Myopia Institute [J].Eur J Ophthalmol, 2021, 31(3): 853-883.
[34]
WALLINE J J, LINDSLEY K B, VEDULA S S, et al.Interventions to slow progression of myopia in children [J].Cochrane Database Syst Rev, 2020, 1(1): CD004916.
[35]
BERTON B, CHENNELL P, YESSAAD M, et al.Stability of ophthalmic atropine solutions for child myopia control [J].Pharmaceutics, 2020, 12(8): 781.
[36]
KIRCHHOFF C, BITAR Y, EBEL S, et al.Analysis of atropine, its degradation products and related substances of natural origin by means of reversed-phase high-performance liquid chromatography [J].J Chromatogr A, 2004, 1046(1/2): 115-120.
[37]
SAITO J, IMAIZUMI H, YAMATANI A.Physical, chemical, and microbiological stability study of diluted atropine eye drops [J].J Pharm Health Care Sci, 2019, 5: 25.
[38]
PINELES S L, KRAKER R T, VANDERVEEN D K, et al.Atropine for the prevention of myopia progression in children: a report by the american academy of ophthalmology [J].Ophthalmology, 2017, 124(12): 1857-1866.
[39]
内瓦卡有限公司.阿托品药物组合物:中国,110621298A[P].2019-12-27.
[40]
沈阳兴齐眼药股份有限公司.一种防治青少年近视的眼用制剂及其制备方法:中国,110833526A [P].2020-02-25.
[41]
河北科技大学.一种治疗近视的滴眼剂及其制备方法:中国,110917133A [P].2020-03-27.
[42]
欧普康视科技股份有限公司.一种延缓治疗青少年近视的滴眼液及其制备方法:中国,112402372A [P].2021-02-26.
[43]
江苏恒瑞医药股份有限公司.一种药物组合物:中国,114668762A [P].2022-06-28.
[44]
杭州赫尔斯科技有限公司.复方药物组合物滴眼液、其制备方法和应用:中国,110974970A [P].2020-04-10.
[45]
杭州赫尔斯科技有限公司.增强低浓度阿托品类药物安全性和临床疗效的组合物:中国,109675038A [P].2019-04-26.
[46]
南京恒道医药科技有限公司.一种硫酸阿托品滴眼液及其制备方法与应用:中国,113262201A [P].2021-08-17.
[47]
新加坡保健服务集团,南洋理工大学,参天制药株式会社.含有阿托品的水性组合物:中国,109310687A [P].2019-02-05.
[49]
OSTROW G I, WIDDER K J, BAKER D S.D2O stabilized pharmaceutical formulations: WO, 2016/196367 A1 [P].2016-12-08.
[50]
艾诺维亚股份有限公司.用于以微剂量的液滴流向眼睛递送阿托品的方法和装置:中国,111655231A [P].2020-09-11.
[51]
苏州欧康维视生物科技有限公司.一种用于预防或治疗眼科疾病的滴眼剂组合物及其制备方法:中国,113440486A [P].2021-09-28.
[52]
沈阳兴齐眼科医院有限公司.药物组合物、其制备方法和用途:中国,114533652A [P].2022-05-27.
[53]
沈阳兴齐眼科医院有限公司.一种提高低浓度阿托品眼用制剂稳定性的方法:中国,110934816B [P].2022-04-08.
[54]
BAUDOUIN C, LABBÉ A, LIANG H, et al.Preservatives in eyedrops: the good, the bad and the ugly [J].Prog Retin Eye Res, 2010, 29(4): 312-334.
[55]
山西利普达医药科技有限公司.一种眼用药物乳剂组合物及其制备方法和应用:中国,114588110B [P].2023-08-04.
[56]
沈阳兴齐眼药股份有限公司.硫酸阿托品眼用凝胶:中国,1206988C [P].2005-06-22.
[57]
肖正连.一种硫酸阿托品眼用即型凝胶:中国,101327216A [P].2008-12-24.
[58]
NI J, YANG R.Topical ophthalmological atropine free base compositions: US, 11191751 [P].2021-12-07.
[59]
MEINERT H, ROY T.Semifluorinated alkanes--a new class of compounds with outstanding properties for use in ophthalmology [J].Eur J Ophthalmol, 2000, 10(3): 189-197.
[60]
AGARWAL P, SCHERER D, GÜNTHER B, et al.Semifluorinated alkane based systems for enhanced corneal penetration of poorly soluble drugs [J].Int J Pharm, 2018, 538(1/2): 119-129.
[61]
沈阳药科大学.一种硫酸阿托品眼用膜剂及其制备方法:中国,111358771B [P]. 2023-01-10.
[62]
JI M, LIU H, MA S, et al.Stable atropine loaded film as a potential ocular delivery system for treatment of myopia [J].Pharm Res, 2021, 38(11): 1931-1946.
2024年第55卷第12期
37
12
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2024.12.001
  • 接收时间:2024-01-05
  • 首发时间:2026-11-18
  • 出版时间:2024-12-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2024-01-05
基金
作者信息
    1.复旦大学药学院,上海 201203
    2.拨康视云生物医药科技(广州)有限公司,广东 广州 510663

通讯作者:

陆伟跃(1960—),男,教授,从事药物靶向策略及递药系统研究。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.12.001
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏